大数据告诉你，买这些股票最赚钱. 财经日历. 提醒. 美国-公布6月5日总钻井总数: 前 值301口: 预测值289口: 公布值284口. 2020-06-06 01:00:00 重要性: 日本-公布4月
提供Akers Biosciences Inc(AKER)股票的行情走势、五档盘口、逐笔交易等实时行情 数据，及Akers Biosciences Inc(AKER)的资讯、公司公告、研究报告、行业研
Akers Biosciences Inc. all SEC filings breakout by MarketWatch. View the AKER U.S. Securities and Exchange Commission reporting information. Stock analysis for Akers Biosciences Inc (AKER:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. * AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers Akers Biosciences Inc. annual stock financials by MarketWatch. View the latest AKER financial statements, income statements and financial ratios.
郑重声明：本网站所刊载的所有资料及图表仅供参考使用。投资者依据本网站提供的信息、资料及图表进行金融、证券等投资 Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. Find the latest Akers Biosciences Inc. (AKER) stock quote, history, news and other vital information to help you with your stock trading and investing. Akers Biosciences Inc. AKER 3.69 0.10 (2.79%). NASDAQ Updated Jun 8, 2020 8:00 PM
由专业分析师提供的Akers Biosciences(AKER)股票分析报告，千股千评。包括行情 走势分析，股价预测，精准股评，投资策略分析及股票买卖操作建议。 提供Akers Biosciences Inc(AKER)股票的行情走势、五档盘口、逐笔交易等实时行情 数据，及Akers Biosciences Inc(AKER)的资讯、公司公告、研究报告、行业研
亿帆医药（个股资料 操作策略 盘中直播 独家诊股）. 亿帆医药事件点评:并购NovoTek,国际化进展再露峥嵘. 亿帆医药 002019. 研究机构：东兴证券 分析
2019年12月6日 在周四的当前时段中，Akers Biosciences，Inc.（NASDAQ：AKER）在近期 随着 具有高市值的美国公司股票（也称为大盘股）的股价在3月23日触 查看最新的Akers Biosciences Inc. (AKER) 股票報價、記錄、新聞及其他重要資訊， 助你賣買股票及投資。 遠期股息及收益率, 無(無). 除息日, 無. 1 年預測目標價, 無 取得Camber Energy, Inc. (CEI) 的最新股票消息和頭條新聞，助你作出交易和投資 決策。 及收益率, 無(無). 除息日, 無. 1 年預測目標價, 無 Akers Biosciences Inc. 提供呼吸酒精偵測器及呼吸酮失重監控裝置等一次性使用之診斷檢測裝置公司Akers Biosciences Inc(AKER.US)成立於1989年，總部位於紐澤西州Thorofare，連同其
金投美股网提供Akers Biosciences Inc(AKER)股票行情,Akers Biosciences Inc股票 价格,Akers Biosciences Inc股票走势分析,Akers Biosciences Inc股票最新消息等
2019年12月6日 在周四的当前时段中，Akers Biosciences，Inc.（NASDAQ：AKER）在近期 随着 具有高市值的美国公司股票（也称为大盘股）的股价在3月23日触 查看最新的Akers Biosciences Inc. (AKER) 股票報價、記錄、新聞及其他重要資訊， 助你賣買股票及投資。 遠期股息及收益率, 無(無). 除息日, 無. 1 年預測目標價, 無 取得Camber Energy, Inc. (CEI) 的最新股票消息和頭條新聞，助你作出交易和投資 決策。 及收益率, 無(無). 除息日, 無. 1 年預測目標價, 無 Akers Biosciences Inc. 提供呼吸酒精偵測器及呼吸酮失重監控裝置等一次性使用之診斷檢測裝置公司Akers Biosciences Inc(AKER.US)成立於1989年，總部位於紐澤西州Thorofare，連同其 金投美股网提供Akers Biosciences Inc(AKER)股票行情,Akers Biosciences Inc股票 价格,Akers Biosciences Inc股票走势分析,Akers Biosciences Inc股票最新消息等
Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally.
Akers Biosciences Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen. 14 May 2020 Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. 14 May 2020 Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP
我们星期天应该买黄金吗
Akers Biosciences (AKER) reports earnings on 8/14/2020. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings.
14 May 2020 Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. 14 May 2020 Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP Akers Bio develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a timely and cost-efficient manner. All of Akers Bio’s rapid, single-use tests are performed in vitro (outside the body) and are Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. Akers Biosciences Inc. all SEC filings breakout by MarketWatch. View the AKER U.S. Securities and Exchange Commission reporting information. Stock analysis for Akers Biosciences Inc (AKER:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. * AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers